Bioventus Inc.
- BVS
- NASDAQ
- Medical devices
- Musculoskeletal Therapies
- Pain Management Devices
- Medical Injections (HA)
$13.49
Today +1.43%Quote Oct 19, 2026, 08:00 PM UTC
+4.49%over the last month
Max drawdown −9.5%From 1-month high −3.8%3 months +13.6%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
About Bioventus
Bioventus Inc., a medical device company, focuses on relieving pain and addressing musculoskeletal therapies in the United States and internationally.
Where the money comes from
Q2 2026 revenue $153.2M
- U.S. Segment$134.5M87.8%
- International Segment$18.7M12.2%
Sector
Healthcare
Industry
Medical devices
Exchange
NASDAQ
Employees
950
Founded
2011
Market value
$921.4M
Quote Oct 19
Floor
$13.43
0.4% below price
Resistance
$13.49
0.0% above price
Price vs analyst targets
7 analysts
Lowest target
$18.00Highest target
$19.00
$18.00Highest target
$19.00
- Price $13.49
- Average target $18.33
- Analysts' target range
The price is below even the lowest analyst target. Analysts' average target sits about 36% higher.
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about BVSPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days free